KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 26th Apr 2024 CHRS stock ended at $2.04. This is 5.70% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Dec 06, 2021 $17.59 $17.85 $16.97 $17.62 734 318
Dec 03, 2021 $18.17 $18.26 $17.63 $17.75 532 641
Dec 02, 2021 $17.77 $18.30 $17.58 $18.06 686 772
Dec 01, 2021 $18.63 $18.66 $17.85 $17.86 630 307
Nov 30, 2021 $18.12 $18.71 $18.04 $18.57 414 650
Nov 29, 2021 $18.42 $18.93 $18.14 $18.20 469 676
Nov 26, 2021 $18.65 $18.94 $17.91 $18.37 451 710
Nov 24, 2021 $18.70 $19.00 $18.51 $18.93 321 578
Nov 23, 2021 $18.25 $18.89 $18.09 $18.79 645 656
Nov 22, 2021 $18.63 $18.85 $18.10 $18.32 423 268
Nov 19, 2021 $18.45 $18.82 $18.12 $18.51 471 054
Nov 18, 2021 $18.44 $18.57 $18.03 $18.52 697 604
Nov 17, 2021 $18.76 $18.97 $18.28 $18.46 511 807
Nov 16, 2021 $18.91 $19.32 $18.62 $18.99 499 514
Nov 15, 2021 $18.78 $19.12 $18.53 $18.92 649 354
Nov 12, 2021 $18.51 $18.97 $18.40 $18.62 479 602
Nov 11, 2021 $18.65 $19.28 $18.50 $18.51 572 100
Nov 10, 2021 $18.49 $19.28 $18.46 $18.86 902 198
Nov 09, 2021 $16.85 $18.86 $16.24 $18.69 1 361 213
Nov 08, 2021 $17.98 $18.13 $17.06 $17.51 808 937
Nov 05, 2021 $17.75 $18.21 $17.43 $17.81 450 509
Nov 04, 2021 $17.71 $17.86 $17.41 $17.67 470 097
Nov 03, 2021 $17.07 $17.70 $16.89 $17.69 1 254 683
Nov 02, 2021 $16.96 $17.37 $16.81 $17.12 511 193
Nov 01, 2021 $16.98 $17.63 $16.82 $16.98 966 251
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT